AFP and liver disorder: Patients in the NLR ≥ 5 group tended to have a higher median AFP level (268 vs. 62, p = 0.02), incidence of PVT (51.9% vs. 32.9%, p = 0.02), more advanced liver disease, including a greater number of patients with CP score 6 (48.1% vs. 32%, p = 0.03) and ALBI grade 2 (67.9% vs. 39.9%, p < 0.001).